Skip to Main Content


Current Issue
Volume 136,
Issue 2,
July 9, 2020

Issue Highlights

Latest in Blood
Free Articles
Laura Palomo; Francesc Solé
DOI: 10.1182/blood.2020005719
Plenary Papers
Luca Malcovati; Kristen Stevenson; Elli Papaemmanuil; Donna Neuberg; Rafael Bejar; Jacqueline Boultwood; David T. Bowen; Peter J. Campbell; Benjamin L. Ebert; Pierre Fenaux; Torsten Haferlach; Michael Heuser; Joop H. Jansen; Rami S. Komrokji; Jaroslaw P. Maciejewski; Matthew J. Walter; Michaela Fontenay; Guillermo Garcia-Manero; Timothy A. Graubert; Aly Karsan; Manja Meggendorfer; Andrea Pellagatti; David A. Sallman; Michael R. Savona; Mikkael A. Sekeres; David P. Steensma; Sudhir Tauro; Felicitas Thol; Paresh Vyas; Arjan A. Van de Loosdrecht; Detlef Haase; Heinz Tüchler; Peter L. Greenberg; Seishi Ogawa; Eva Hellstrom-Lindberg; Mario Cazzola
DOI: 10.1182/blood.2020004850
First Edition
Ellen-Sofie Hansen; Kristian Hindberg; Nadezhda Latysheva; Pål Aukrust; Thor Ueland; John-Bjarne Hansen; Sigrid K. Braekkan; Vânia Maris Morelli
DOI: 10.1182/blood.2019004572
Clinical Trials and Observations
Bianca Rocca; Alberto Tosetto; Silvia Betti; Denise Soldati; Giovanna Petrucci; Elena Rossi; Andrea Timillero; Viviana Cavalca; Benedetta Porro; Alessandra Iurlo; Daniele Cattaneo; Cristina Bucelli; Alfredo Dragani; Mauro Di Ianni; Paola Ranalli; Francesca Palandri; Nicola Vianelli; Eloise Beggiato; Giuseppe Lanzarone; Marco Ruggeri; Giuseppe Carli; Elena Maria Elli; Monica Carpenedo; Maria Luigia Randi; Irene Bertozzi; Chiara Paoli; Giorgina Specchia; Alessandra Ricco; Alessandro Maria Vannucchi; Francesco Rodeghiero; Carlo Patrono; Valerio De Stefano
DOI: 10.1182/blood.2019004596


Message from ASH President on Diversity, Equity, and Inclusion

Authors and Reviewers: New COVID-19 Announcement

Featured Content

Blood Podcast: Season 1, Episode 28

This week we will review data that suggests the pro-inflammatory environment associated with aging alters hematopoietic stem cell function by inducing IL27Ra expression, examine a study attempting to optimize antiplatelet therapy in essential thrombocythemia, and learn more about a study by investigators who have proposed that myelodysplastic syndrome patients with mutations in SF3B1 identify a new subtype of that disease.

SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS

The World Health Organization’s classification of hematopoietic and lymphoid tumors has worked to integrate morphology and genetics, but del(5q) remains the only molecularly defined subtype of myelodysplasia (MDS). In a Special Report that is also this issue’s Plenary Paper, the International Working Group for the Prognosis of MDS makes the case for designating SF3B1-mutant MDS as a second molecularly defined subtype with good prognosis and increased likelihood of response to luspatercept.

A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia

Treatment with once-daily aspirin (acetylsalicylic acid [ASA]) is recommended in essential thrombocythemia (ET) based on efficacy studies in polycythemia vera, but ASA may not provide sufficient platelet inhibition in ET because of increased platelet activation. Rocca et al compared efficacy of ASA in suppressing thromboxane excretion with once-, twice-, and 3-times–daily dosing. Twice-daily dosing has superior antiplatelet activity compared to once-daily dosing, with no further improvement with treatment 3 times daily.

Plasma microparticles of sickle patients during crisis or taking hydroxyurea modify endothelium inflammatory properties

Garnier and colleagues studied erythrocyte-derived microparticles (MPs) isolated from the plasma of patients with sickle cell disease (SCD) before and after hydroxyurea treatment and during vaso-occlusive crisis. They demonstrated that increased phosphatidylserine (PS) expression on SCD MPs increases endothelial ICAM-1 and neutrophil adhesion at baseline, and this was markedly increased during crisis. Furthermore, PS expression was decreased by hydroxyurea, suggesting a novel effect in preventing crisis.

Aging-induced IL27Ra signaling impairs hematopoietic stem cells

Aging-associated changes in hematopoietic stem cells lead to myeloid skewing, anemia of aging, and increased risk of myeloid malignancy. He et al confirmed that these changes are closely linked to increased expression of inflammatory cytokines, demonstrating that an age-associated increase in tumor necrosis factor α leads to increased expression of interleukin 27 receptor α (IL27Ra) and that these IL27Ra+ stem cells have impaired reconstitution capacity and increased myeloid skewing.

Epo receptor signaling in macrophages alters the splenic niche to promote erythroid differentiation

Chen and colleagues present a novel paradigm of the role of erythropoietin (Epo) in stress hematopoiesis. Using a mouse model, they demonstrated that Epo acts to modulate macrophages in the erythropoietic niche to suppress Wnt expression, suppressing Wnt-induced proliferation of early progenitors, and to increase production of prostaglandin E2, inducing erythroid progenitors to differentiate.

Close Modal
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close Modal
Close Modal